Irmandade DA Santa Casa De Misericordia De Vitoria

Irmandade DA Santa Casa De Misericordia De Vitoria, a foreign government entity based in Vitória, Brazil, operates as a sub-recipient on federal research grants focused on tuberculosis immunology and bacterial pathogenesis, exclusively through Rutgers The State University of New Jersey as the prime grantee. The organization holds no prime federal contracts or grants and does not sit on any federal contract vehicles; all three of its recent federal awards are sub-grants from the National Institute of Allergy and Infectious Diseases (NIAID) within the Department of Health and Human Services.

The vendor's entire federal footprint derives from a single customer — NIAID — which has issued three sub-grant awards over the past fifteen months. The sub-grants support research into bacterial and host heterogeneity in tuberculosis latency, persistence, and progression (two awards, issued in October 2024 and January 2026) and mechanisms of interferon-gamma-independent T cell and B cell-mediated protection in tuberculosis (one award, issued in June 2025). Combined dollars obligated across all three sub-grants total $115 thousand. Activity is minimal and flat — one award per calendar year across 2024, 2025, and 2026 — with no indication of growth or diversification beyond tuberculosis immunology research. The organization's role is limited to research execution as a sub-grantee under Rutgers' prime stewardship, with no contracting capability, no vehicle positions, and no sub-contract footprint in the federal space. Federal contractors evaluating partnership or acquisition opportunities should view this entity as a specialized research institute with narrow, grant-funded tuberculosis work channeled through a single university prime, rather than as a vendor capable of independent federal procurement engagement or teaming arrangements outside the research-grant space.